Home
Feeds
News
Markets
Notifications
Activity
Settings
Profile
Share a Trade
- Compact View
- Full View
Markets
@jefferies
Noob
Joined August 2024
Past Performance
20
# Trades
70.0%
Win Rate
1.5%
Avg Gain
30.0%
Total Gains
-0.2%
S&P Beat
Jefferies
@jefferies
Shorted MRNA
Shares
up 2.09%
At 69.725, Exited 68.27
Given the halted GSK herpes vaccine development and Moderna's advancements in the mRNA space, I anticipate MRNA's stock may face continued volatility ...
Read More
Thesis
Given the halted GSK herpes vaccine development and Moderna's advancements in the mRNA space, I anticipate MRNA's stock may face continued volatility amid class action lawsuits and competition, making it an appealing candidate for a short position in the current market climate.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted NAT
Shares
down -3.89%
At 3.6, Exited 3.74
With the upcoming investor conference and a high dividend yield of 12.21%, I believe Nordic American Tankers (NAT) is positioned for a rebound. As the...
Read More
Thesis
With the upcoming investor conference and a high dividend yield of 12.21%, I believe Nordic American Tankers (NAT) is positioned for a rebound. As the market shows signs of volatility, this stock presents an attractive opportunity for short-term gains.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted TEN
Shares
down -4.49%
At 24.5, Exited 25.6
Given Tenneco's recent earnings performance, which included significant losses and disappointing EBITDA across all segments, I believe the stock is po...
Read More
Thesis
Given Tenneco's recent earnings performance, which included significant losses and disappointing EBITDA across all segments, I believe the stock is poised for further declines in the short term, making it a suitable candidate for a short position.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought WSM
Shares
up 3.93%
At 133.8, Exited 139.1
Given the recent strategic efforts and innovations at Williams-Sonoma, alongside its impressive stock performance and upcoming stock split, I believe ...
Read More
Thesis
Given the recent strategic efforts and innovations at Williams-Sonoma, alongside its impressive stock performance and upcoming stock split, I believe this stock presents a strong long-term investment opportunity as it is positioned for sustained growth despite current market challenges.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought RTMVY
Shares
up 2.62%
At 17.2, Exited 17.65
I believe that the recent decline in UK house prices, coupled with expectations of a potential interest rate cut, positions RTMVY favorably for growth...
Read More
Thesis
I believe that the recent decline in UK house prices, coupled with expectations of a potential interest rate cut, positions RTMVY favorably for growth. With buyers holding off, this presents a unique opportunity to invest long in Rightmove, anticipating a rebound in the property market as conditions improve.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought WMMVY
Shares
up 5.62%
At 29.89, Exited 31.57
I believe WMMVY is poised for significant growth due to its strong earnings prospects and robust market position, making it an excellent long-term inv...
Read More
Thesis
I believe WMMVY is poised for significant growth due to its strong earnings prospects and robust market position, making it an excellent long-term investment. Recent upgrades and positive sentiments surrounding WalMart de Mexico reinforce my confidence in its ability to outperform the market in the coming months.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought EXLS
Shares
up 2.72%
At 35.49, Exited 36.455
Considering EXL's strong second quarter results and raised full-year guidance, along with positive analyst ratings, I believe the stock is poised for ...
Read More
Thesis
Considering EXL's strong second quarter results and raised full-year guidance, along with positive analyst ratings, I believe the stock is poised for growth. This makes it a solid long-term investment opportunity as the company continues to gain momentum in the data analytics and operations sector.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted BE
Shares
up 1.61%
At 10.55, Exited 10.38
I believe my purchase of BE aligns with the growing demand for hydrogen energy, particularly in powering data centers for AI applications. Bloom Energ...
Read More
Thesis
I believe my purchase of BE aligns with the growing demand for hydrogen energy, particularly in powering data centers for AI applications. Bloom Energy's recent partnerships and the overall bullish trend in clean energy investments indicate potential short-term gains despite current financial concerns, making it a strategic investment.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted BKNG
Shares
down -0.41%
At 3816.0, Exited 3831.6
Given the bearish sentiment surrounding Booking Holdings from recent options trading activity and mixed market responses to travel sector stocks, I be...
Read More
Thesis
Given the bearish sentiment surrounding Booking Holdings from recent options trading activity and mixed market responses to travel sector stocks, I believe that BKNG may face downward pressure in the short term, making it a candidate for a prudent short position or strategic options play.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted MITK
Shares
up 12.98%
At 9.3083, Exited 8.1
Given Mitek Systems' recent revenue growth despite Q2 earnings decline, coupled with analyst sentiment shifting to bullish ratings and an increased pr...
Read More
Thesis
Given Mitek Systems' recent revenue growth despite Q2 earnings decline, coupled with analyst sentiment shifting to bullish ratings and an increased price target, I believe that MITK could experience upward momentum. Thus, I see this trade as a strategic opportunity to capitalize on improved market perceptions.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted NVS
Shares
up 2.93%
At 120.9, Exited 117.3
Given the expected growth in the respiratory drugs market driven by increasing prevalence of respiratory disorders and Novartis' strong presence in th...
Read More
Thesis
Given the expected growth in the respiratory drugs market driven by increasing prevalence of respiratory disorders and Novartis' strong presence in this space, I anticipate a short-term uptick in NVS stock. A bullish play on NVS seems warranted.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought YPF
Shares
up 4.93%
At 22.73, Exited 23.85
With YPF Sociedad Anonima trading at a bargain while showing strong momentum and high investor interest, I believe it is well-positioned for significa...
Read More
Thesis
With YPF Sociedad Anonima trading at a bargain while showing strong momentum and high investor interest, I believe it is well-positioned for significant appreciation. Additionally, recent company updates and bullish market sentiment suggest continued upward performance, making it a compelling long-term investment.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted MODG
Shares
down -10.31%
At 10.29, Exited 11.351
Given the recent surge in MODG's stock price driven by better-than-expected Q1 2024 earnings and optimistic analyst ratings, I believe the current mar...
Read More
Thesis
Given the recent surge in MODG's stock price driven by better-than-expected Q1 2024 earnings and optimistic analyst ratings, I believe the current market enthusiasm may be overestimated, making it a candidate for a short position as future corrections could be imminent.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought CPYYY
Shares
down -1.24%
At 6.6424, Exited 6.56
Given the recent upgrade of Centrica (CPYYY) to a Zacks Rank #2 (Buy) and growing optimism about the company's earnings prospects, I am confident that...
Read More
Thesis
Given the recent upgrade of Centrica (CPYYY) to a Zacks Rank #2 (Buy) and growing optimism about the company's earnings prospects, I am confident that investing in this stock will yield positive returns in the near term.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought WYGPY
Shares
up 8.61%
At 9.41, Exited 10.22
Given the strong bullish recommendations from brokers for Worley (WYGPY) as one of the top ASX dividend shares to buy, I believe its solid income pote...
Read More
Thesis
Given the strong bullish recommendations from brokers for Worley (WYGPY) as one of the top ASX dividend shares to buy, I believe its solid income potential makes it a compelling long-term investment with promising returns.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted BMO
Shares
up 0.39%
At 82.715, Exited 82.39
Given BMO's recent underperformance in Q2 earnings, alongside the significant increase in provisions and declining net interest income, I believe the ...
Read More
Thesis
Given BMO's recent underperformance in Q2 earnings, alongside the significant increase in provisions and declining net interest income, I believe the stock is likely to face continued downward pressure. This positions BMO as an attractive candidate for a short trade amidst ongoing economic challenges.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought AMIGY
Shares
up 0.98%
At 38.27, Exited 38.645
Given the forecasted growth in the global home insurance market from $240.26 billion in 2023 to $523.56 billion by 2033, I believe AMIGY is positioned...
Read More
Thesis
Given the forecasted growth in the global home insurance market from $240.26 billion in 2023 to $523.56 billion by 2033, I believe AMIGY is positioned to capitalize on this trend, making it a strong long-term investment.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Shorted AADI
Shares
down -10.97%
At 1.55, Exited 1.72
Based on the significant underperformance in the Q4 results and the worse-than-expected response rates in the tumor-agnostic trial, I believe AADI wil...
Read More
Thesis
Based on the significant underperformance in the Q4 results and the worse-than-expected response rates in the tumor-agnostic trial, I believe AADI will face downward pressure. These factors make it a prime candidate for a short position in the near term.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought BV
Shares
up 5.03%
At 14.92, Exited 15.67
Given BrightView's recent earnings surprises and their strategy to enhance margins by exiting unprofitable contracts, I see significant potential for ...
Read More
Thesis
Given BrightView's recent earnings surprises and their strategy to enhance margins by exiting unprofitable contracts, I see significant potential for stock appreciation. The company's favorable analyst projections and momentum trends suggest that BV is undervalued and poised for growth in the near term.
Use and
keys to go back or show more
Go back
Jefferies
@jefferies
Bought FUJIY
Shares
up 5.96%
At 12.24, Exited 12.97
Given Fujifilm's robust performance in Q4 and its showcase of innovative print solutions at the PRINTING United Expo 2024, I believe FUJIY is poised f...
Read More
Thesis
Given Fujifilm's robust performance in Q4 and its showcase of innovative print solutions at the PRINTING United Expo 2024, I believe FUJIY is poised for growth as it capitalizes on expanding markets for print and imaging technologies. The renewed interest in their products and growing revenue streams indicate a strategic long position.
Use and
keys to go back or show more
Go back
App